Global Health Press

Category - Latest Science

ViVa News — Week 28

Shigella vaccine breakthrough The live-attenuated oral Shigella sonnei vaccine WRSs2 reported 89% efficacy against shigellosis in a phase 2 controlled human infection trial — the highest protection rate ever recorded...

Literature update ViVa week 28-2026

1. Five years after the global TB vaccine roadmap launched, progress is real but painfully thin This narrative review updates the 2021 Global Roadmap for tuberculosis (TB) vaccine research and development, assessing...

Literature update ViVa week 26-2026

1. Avian influenza reaches European dairy herds – silent spread in cattle demands integrated surveillance A farm-based investigation in the Netherlands screened milk and serum from 72 lactating cows and 38 youngstock...